Introduction
The incidence of inflammatory bowel disease (IBD) peaks around women's reproductive age and it has been linked to increased risks of pre-term birth and low birth weight which may lead to perinatal mortality. 1 However the results from previous studies are inconsistent perhaps because most have been inadequately powered to provide reliable or precise
figures. [2] [3] [4] [5] [6] Even a meta-analysis by Cornish et.al 7 which found 97% and 34% relative increases in the risk of pre-term births among those diagnosed with Ulcerative Colitis (UC) and Crohn's Disease (CD) respectively only included 1831 births to mothers with UC and 1005 to mothers with CD. This meta-analysis also reported a statistically significant 3-fold increase in the incidence of low birth weight among the children of mothers with CD compared to non-IBD controls, though there was no significant increase in low birth weight for children of mothers with UC. It is also not clear how adverse birth outcome varies by various mode of deliveries among women with IBD which may be medically driven because of complications related or unrelated to IBD. Furthermore, of studies that have found a significant positive association between IBD and caesarean section 3, 5-8 most were unable to distinguish between the types of caesarean section (emergency versus elective). Finally, the potential impact of prior surgical intervention among women with IBD on these pregnancy outcomes also remains unknown. Accurate estimates of the risk of adverse birth outcomes and pregnancy related complications that are generalizable to the majority of pregnancies in women with IBD will aid both women and practitioners in better decision making. Therefore the aim of this study was to look at the contemporary risk of pregnancy associated complications and adverse birth outcomes among women diagnosed with IBD and assess its variation by IBD type and surgical intervention.
Method

Study population
We used the Clinical Practice Research Datalink (CPRD) 9 which is a large longitudinal UK database that contains the anonymised primary care records of patients in computerised form.
The CPRD includes practices where staff have been trained to enter data to the necessary standard for research, and identifies the date at which this standard is reached. All patients within a participating practice are automatically included. Data from around 53% of the CPRD practices are also linked to Hospital Episode Statistics (HES) 10, 11 data which contains more detailed information on all hospitalisations in England, including all discharge diagnoses and procedures. As HES only covers English hospitals, practices from Northern
Ireland, Wales and Scotland are excluded. The linked portion of the CPRD has been shown to be similar in terms of age and sex distribution to the UK population published by the Office for National Statistics (ONS) 12 . Diagnoses of IBD 13 in primary care and delivery/birth information in HES maternity data 14 have been validated to external sources with positive predictive values of 92% and 93% respectively.
Defining cases
We used as our source population the entirety of CPRD records for practices linked to HES data, during the period for which this linkage was available (1997) (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) . Women in this population aged 15-44 years with HES-recorded singleton pregnancies ending in a live birth or a stillbirth between 1997 and 2012 were identified from our study population. Pregnant women were defined as having IBD during pregnancy if they had ever had a diagnosis before delivery or if they had a diagnosis after delivery but a prescription of 5-ASA at some point before delivery. Information on the IBD diagnosis was extracted using both primary and secondary care data. Pregnant women with IBD were classified as having CD if they had diagnoses specifying this condition regardless of whether they also had diagnoses of UC, as having UC if they had recordings of UC but not CD, and as having unclassified IBD if their coding for IBD did not specify CD or UC.
For pregnant women with IBD, we also extracted information on surgical interventions that included women undergoing small bowel (e.g. excision of lesion of ileum), large bowel (e.g. colectomy), perianal surgery (e.g. Perianal excision lesion of rectum) or pouch surgery (e.g.
anastomosis of ileum to rectum) using their both primary and secondary care records (code list available on request). In order to correctly ascertain pouch surgeries among women with UC, we also reviewed their surgical records. We considered women as having surgical intervention for IBD if they had a record for a relevant surgical procedure at any point from diagnosis up to their date of delivery. Our control population was pregnant women without a diagnosis of IBD in their primary or secondary care records.
Defining outcomes
From HES, we extracted information on pregnancy related complications (postpartum haemorrhage, antepartum haemorrhage, gestational diabetes, venous thromboembolism and pre-eclampsia/eclampsia) using previously established methodology. 15, 16 Mode of delivery was categorised as normal vaginal delivery, assisted vaginal delivery (forceps, breech or vacuum), emergency and elective caesarean. We also extracted information on adverse birth outcomes (pregnancies resulting in pre-term births (<37 weeks of gestation), post-term births (>41 weeks), stillbirths or infants born with low birth weight (<2500 grams)).
Defining maternal co-variables analysis. For the purpose of this study, the categorisation of surgical intervention was not considered as mutually exclusive (i.e. if a woman had undergone more than one type of surgery prior to a pregnancy this was included in the analysis). As we did not have information on the severity of disease, we identified IBD case prescribed steroids at any point in time during pregnancy to assess the impact of disease activity on adverse outcomes. A clustering term was fitted in the models to account for women experiencing more than one pregnancy during the study period. All analyses were carried out using Stata MP 13.0 (Stata Corp., College Station, TX, USA).
Ethical consideration
This study was approved by the CPRD's scientific advisory committee (ISAC) (reference number= 10_193)
Results
Study population
Among 276,719 women in our study population, there were 364,363 singleton pregnancies resulting in a live birth or a stillbirth. The proportion of pregnancies in women who had IBD diagnosed at some point before delivery was 0.5% (n=1,969). The majority (n=1,664 (85%))
of IBD diagnoses were made more than one year before delivery. Of all women with IBD, 51% (n=1,002) had CD and 45% (n=884) had UC with the remainder (n=83, 4%) of cases being of unclassified IBD type. Table 1 shows the maternal characteristics of mothers with and without IBD. Compared to controls, pregnant women with IBD were slightly older and more likely to be underweight particularly those with CD. Those with UC had a higher prevalence of diabetes and were less likely to be smokers compared to the control population whereas women with CD were more likely to be smokers. These differences were statistically significant (p-value <0.01). Overall, we found modestly increased risks of pregnancy related complications and adverse birth outcomes among pregnant women with IBD compared to the control population ( Table 2 ). The risk for gestational diabetes, pre-eclampsia/eclampsia, preterm birth and low birth weight was further increased among cases prescribed steroids during pregnancy (supplementary table 1 ).
Adverse pregnancy and birth outcome among CD
The absolute risks of antepartum and postpartum haemorrhages among those with CD were 5.2% and 12.3% respectively. This corresponded to a 0.5% and 2.6% absolute excess risk respectively compared to the control population (Table 2) . Compared to controls, women with CD were more like to undergo elective caesarean section with an absolute risk of 17.2% vs 9.7%, i.e. almost 2-fold (Adjusted odds ratio (AOR)=1.97; 95%CI 1.61-2.40) whereas the increase was more modest for emergency caesarean section (AOR=1.31; 95%CI 1.08-1.59) ( smaller babies (birth weight<2500 grams) respectively compared to the control population.
Even among women with CD delivering at term, we found an increased risk of having babies with low birth weight, although the association was not statistically significant (AOR=1.37 95%CI 0.92-2.04). We also found that mothers with CD had babies with a mean weight 80 grams lower (95%CI -40 to -120) compared to those without IBD. Finally the positive associations observed between CD and postpartum haemorrhage, pre-term birth and low birth weight remained when we excluded pregnant women who underwent caesarean section ( Figure 1 ) and excluded CD cases with perianal disease (supplementary table 2 ).
Adverse pregnancy and birth outcome among UC Among pregnant women with UC, we did not observe a significantly increased risk of antepartum haemorrhage, postpartum haemorrhage, pre-eclampsia/eclampsia or emergency caesarean section compared to women without IBD ( Table 2 ). The absolute rate of elective caesarean section was higher among those with UC compared to controls (13.7% versus 9.7%); however this increased risk was not statistically significant ( Table 2 and Table 3 ). We observed that women with UC were 33% more likely to have pre-term births (AOR=1.33 95%CI 1.06-1.67, absolute risk 8.5% in UC vs 6.5% in controls). This effect was also statistically significant when we excluded women who underwent caesarean sections ( Figure   2 ). Finally, pregnant women with UC were not at a higher risk of stillbirths or giving birth to babies with low birth weight. There was also no statistically significant difference in the mean birth weight among cases and controls (Mean difference=-28 grams 95%CI -13 to 70) ( Table 2) .
Surgical intervention for IBD and adverse pregnancy and birth outcomes Some form of surgical intervention for IBD occurred before 344 (17.4%) of the deliveries.
We found no increased risk of pregnancy related complications and adverse birth outcomes occurring in pregnancies following surgical intervention compared to those with IBD without surgical intervention (Table 4 
Discussion
Main findings
In this large cohort study of more than 360,000 singleton pregnancies resulting in a live birth or a stillbirth, we have provided population-based estimates of the proportion of such pregnancies complicated by IBD that have pregnancy related complications and adverse birth outcomes. Around 0.5% of these pregnancies were among women who have IBD, of which more than half had CD. Women with CD were at increased risk of postpartum haemorrhage, caesarean section, pre-term birth and low birth weight compared to those without an IBD diagnosis with the absolute excess risk ranging between 1.6% (low birth weight) and 2.6%
(pre-term birth). Given baseline risks of 4.5% low birth weight and 6.5% preterm birth in the general population (without IBD), these increases are modest. Women with CD were also more likely to undergo both elective and emergency caesarean sections. The increased risk of pre-term birth and low birth weight among women with CD remained when we excluded women who underwent caesarean section. In contrast, those with UC were only at an increased risk of pre-term delivery and this association remained statistically significant when we excluded those who underwent caesarean section delivery. We found no increased risks of pregnancy related complications and adverse birth outcomes among those with prior surgical intervention for IBD compared with those with IBD but without a history of surgical intervention. However, there was an increased risk of elective caesarean section associated with a history of surgical intervention which was more apparent in the UC group.
Strengths and limitations
We have conducted one of the largest single studies yet to determine the risk of pregnancy related complications and adverse birth outcomes in women with IBD. Our study used an open cohort approach, with prospectively collected data and utilised information from linked primary and secondary care data sources from across England covering 3% of the total UK population with a similar age and sex distribution to the population as a whole. 17 Our study findings should therefore not only be generalisable to singleton pregnancies resulting in a live birth or a stillbirth in England but also to other developed nations with similar health care systems and baseline incidence of adverse outcome. As HES is the primary source of maternity statistics in England and its birth outcomes have been externally validated with high accuracy, 14 we believe that under recording of birth outcomes and differential recording of adverse pregnancy related complications/outcomes between women with and without diagnosed IBD is unlikely. Our use of linked data from both primary and secondary care also allows better adjustment for important confounding factors such as BMI, smoking status and maternal diabetes.
A potential weakness of this study is that since we used anonymised patient records and had no direct access to the patients, we were dependent on family doctors entering data accurately in CPRD. However, the diagnosis of IBD has been previously validated in UK electronic general practice data with a high degree of accuracy so we think it unlikely that there is major error in our findings due to misattribution of the diagnosis of IBD. 13 We also acknowledge that there are other commonly investigated outcomes (spontaneous abortion, APGAR score and neonatal death) which we were not able to assess in our study due to the lack of complete and reliable data. However, previously our group found very limited increased risk of major congenital anomalies in children born to mothers with IBD 18 using another similar dataset which had linked mother baby information.
Interpretation in the context of previous literature
Our finding of increased risk of pre-term birth among babies born to mothers with CD is consistent with most previous studies although the magnitude of the effect that we observed in our study was slightly lower than most 2, 4-6 but not all previous studies. [19] [20] [21] It should be noted that the greatest apparent magnitudes (more than 2-fold increased risk compared to controls) for this association have been in general reported by small often single centre studies 2, 4-6 based on 38 to 177 cases. However, the few large multicenter population based studies with more than 500 cases are more similar in their findings to our own. 19, 20, 22 Similarly, our finding of an increased risk of having babies with low birth weight among CD mothers is in line with the existing literature. 19, 20 We showed that pregnant women with UC are more likely to have pre-term birth compared to the control population whereas the risk of having babies with low birth weight is similar between cases and controls. This finding is supported by a number of previous studies 2, 4, 23 and a meta-analysis. 7 In contrast, Dominitz et al 5 in their multicenter hospital based study, found no association between prematurity and UC which may be due to the database and methodology used to define their exposure. For instance, the authors established the presence or absence of IBD through the review of diagnoses listed in the discharge record from hospitalisation associated with birth leading to under ascertainment of IBD cases. This is evident by their much lower prevalence of IBD in pregnancy (0.03%) compared to our own (0.5%). Moreover, the IBD definition was not validated in this previous study which may have led to misclassification between CD and UC given that the study also reported a much higher increased risk (4-fold) of pre-term birth associated with CD. Similarly, Bortoli et al 21 found no evidence of pre-term birth among those with UC or CD which may be attributed to their small number of cases and high dropout rate which may have biased their estimates. Our stratified analyses by mode of delivery show evidence that prematurity and babies born with low birth weight observed among IBD cases may be independent of factors and/or complications leading to medically driven caesarean section for which further studies are needed. This effect was more prominent among those with UC even after excluding women who had pouch surgery. In order to better understand the relationship between caesarean section and IBD, it may be important to explore the primary indication for caesarean section (IBD versus other medical causes) for which we do not have data.
We found that among those who underwent surgical intervention prior to delivery, there was no increased risk of adverse birth outcomes compared to those with IBD without surgical intervention. Whilst these findings may be reassuring, Stephansson et al 20 reported a more than 53% increased risk of pre-term birth among Swedish and Danish pregnant women with a history of CD related surgery. This may be due to the fact that this previous study was based on inpatient registry data with limited information on outpatient visits. Therefore their cases may be more likely to be those with moderate to severe disease leading to slight overestimation of the actual risk. In contrast our study provides a more representative picture of IBD with disease severity ranging from mild to severe.
Our finding of increased risk of postpartum haemorrhage among those with CD contradicts the findings of Broms et al. 24 This may be due to the difference in study design and population studied. For instance, postpartum haemorrhage is more common in the UK compared to Sweden (10% versus 6%). Additionally, there is also a marked difference between the incidences of caesarean sections between the two counties (17% in Sweden versus 26% in the UK) which may be a contributory factor. Our increased risk observed for postpartum haemorrhage was however independent of caesarean section.
In conclusion, women with CD are at increased risk of pre-term birth, low birth weight and postpartum haemorrhage independent of any effect that either IBD or its complications have in increasing caesarean section among these women. In contrast women with UC are only at higher risk of pre-term births and for all IBD there was no association with stillbirth. Whilst IBD related surgery itself is not associated with the risk of adverse pregnancy related complications, it is may be considered an important factor in the decision for elective caesarean section especially among those with UC. These findings should be carefully considered by women with IBD planning pregnancy and when in clinical consultation with pregnant women with IBD. Despite the fact that we have shown significantly increased risks for certain pregnancy related complications and adverse birth outcomes particularly among those with CD, the absolute differences are small indicating that most women with CD and UC will have an uncomplicated pregnancy ending in favourable outcomes. Includes pregnancies of women resulting in stillbirth, pre-term birth or infant born with low birth weight 5 Analysis based on pregnancies with normal gestational length (37-41 weeks) 6 Analysis based on pregnancies resulting in live births with baby's weight between 2500-4500 grams Includes pregnancies of women resulting in stillbirth, pre-term birth or infant born with low birth weight 5 Analysis based on pregnancies with normal gestational length (37-41 weeks) 6 Analysis based on pregnancies resulting in live births with baby's weight between 2500-4500 grams -<3 cases omitted. 
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